Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 1.00 |
| ▸ | ADORA1 | P30542 | 1/20 | 1.00 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.56 |
| ▸ | PI4KA | P42356 | 8/20 | 0.53 |
| ▸ | PI4K2B | Q8TCG2 | 8/20 | 0.53 |
| ▸ | PI4K2A | Q9BTU6 | 8/20 | 0.53 |
| ▸ | PI4KB | Q9UBF8 | 8/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8566 | 1.00 | ADORA2A (1.00) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL8342350 | 0.90 | ADORA2A (0.81) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| Pyrophosphoric Acid SCHEMBL6065979 | 0.84 | ADORA2A (0.71) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL42314 | 0.79 | ADORA2A (0.66) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL29400753 | 0.79 | ADORA2A (0.66) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL1059581 | 0.78 | NUDT1 (0.68) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL30109321 | 0.78 | NUDT1 (0.68) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| Niacinamide SCHEMBL3281893 | 0.76 | ADORA2A (0.58) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL842440 | 0.76 | ADORA2A (0.61) | ADORA2AADORA1NUDT1PI4KAPI4K2B | |
| SCHEMBL931970 | 0.76 | ADORA2A (0.61) | ADORA2AADORA1NUDT1PI4KAPI4K2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731186-A2 | METHODS AND COMPOSITIONS FOR TREATING EPITHELIAL DISEASES | The Regents of the University of California (US) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024263919-A2 | METHODS AND COMPOSITIONS FOR TREATING EPITHELIAL DISEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-12-26 | — | — | WO | disclosed |
| EP-4298104-A1 | HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION | Agilent Technologies, Inc. (US) | 2024-01-03 | — | — | EP | disclosed |
| WO-2022183081-A9 | HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION | AGILENT TECHNOLOGIES, INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| WO-2022268932-A1 | SYSTEMS AND METHODS FOR SINGLE CELL ANALYSIS | THERMO FISHER SCIENTIFIC GENEART GMBH (DE) | 2022-12-29 | — | — | WO | disclosed |
| EP-4069205-A1 | EXOSOMES-BASED THERAPY FOR LIVER FIBROSIS AND OTHER DISEASES ASSOCIATED WITH FIBROSIS | Board of Regents, The University of Texas System (US) | 2022-10-12 | — | — | EP | disclosed |
| WO-2022183081-A1 | HYDROCINNAMOYL PROTECTED RIBOGUANOSINE PHOSPHORAMIDITES FOR DECREASING DEPYRIMIDINATION FROM ALKYL AMINE EXPOSURE DURING FINAL DEPROTECTION | AGILENT TECHNOLOGIES, INC. (US) | 2022-09-01 | — | — | WO | disclosed |
| WO-2022162536-A1 | SINGLE STRANDED DNA ENZYME INHIBITORS | MASSEY UNIVERSITY (NZ) | 2022-08-04 | — | — | WO | disclosed |
| EP-3980563-A2 | NTRK FUSION MOLECULES AND USES THEREOF | Foundation Medicine, Inc. (US) | 2022-04-13 | — | — | EP | disclosed |